GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G&E Healthcare Co Ltd (XKRX:299480) » Definitions » Capex-to-Revenue

G&E Healthcare Co (XKRX:299480) Capex-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is G&E Healthcare Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

G&E Healthcare Co's Capital Expenditure for the six months ended in . 20 was ₩0.00 Mil. Its Revenue for the six months ended in . 20 was ₩0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.


G&E Healthcare Co Capex-to-Revenue Historical Data

The historical data trend for G&E Healthcare Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G&E Healthcare Co Capex-to-Revenue Chart

G&E Healthcare Co Annual Data
Trend
Capex-to-Revenue

G&E Healthcare Co Semi-Annual Data
Capex-to-Revenue

Competitive Comparison of G&E Healthcare Co's Capex-to-Revenue

For the Biotechnology subindustry, G&E Healthcare Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G&E Healthcare Co's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G&E Healthcare Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where G&E Healthcare Co's Capex-to-Revenue falls into.



G&E Healthcare Co Capex-to-Revenue Calculation

G&E Healthcare Co's Capex-to-Revenue for the fiscal year that ended in . 20 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- () /
=N/A

G&E Healthcare Co's Capex-to-Revenue for the quarter that ended in . 20 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- () /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G&E Healthcare Co  (XKRX:299480) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


G&E Healthcare Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of G&E Healthcare Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


G&E Healthcare Co (XKRX:299480) Business Description

Traded in Other Exchanges
N/A
Address
No. 92, Keji 5th Road, Annan District, Tainan, TWN, 70955
G&E Healthcare Co Ltd, formerly G&E Biotech Co Ltd is a biopharmaceutical company focused on the development and commercialization of novel botanical extraction technology and products. It offers a range of products that include Hepato Protective Agent (Hepanamin) which prevent and cure for acute and chronic hepatitis, fatty liver conditions and liver toxicity infections, Botanical Healthcare product, and Botanical Anti-aging cosmetics.

G&E Healthcare Co (XKRX:299480) Headlines

No Headlines